688393 安必平
已收盘 04-03 15:00:01
资讯
新帖
简况
安必平(688393)发布关于变更项目合伙人及签字会计师的公告,4月2日股价下跌3.28%
证券之星 · 04-02 23:08
安必平(688393)发布关于变更项目合伙人及签字会计师的公告,4月2日股价下跌3.28%
安必平最新公告:宫颈细胞数字病理图像辅助诊断软件获三类医疗器械注册证
证券之星 · 03-30
安必平最新公告:宫颈细胞数字病理图像辅助诊断软件获三类医疗器械注册证
每周股票复盘:安必平(688393)预计2026年日常关联交易额1996.65万元
证券之星 · 03-29
每周股票复盘:安必平(688393)预计2026年日常关联交易额1996.65万元
安必平(688393)披露预计2026年度日常关联交易额度公告,3月26日股价下跌3.41%
证券之星 · 03-26
安必平(688393)披露预计2026年度日常关联交易额度公告,3月26日股价下跌3.41%
方舟健客任命医疗行业资深人士王海蛟为首席执行官,此前公司创下年度增长与盈利纪录
美股速递 · 03-26
方舟健客任命医疗行业资深人士王海蛟为首席执行官,此前公司创下年度增长与盈利纪录
每周股票复盘:安必平(688393)2025年净亏4497万
证券之星 · 03-01
每周股票复盘:安必平(688393)2025年净亏4497万
安必平发布2025年度业绩快报,亏损0.45亿元
证券之星 · 02-27
安必平发布2025年度业绩快报,亏损0.45亿元
股市必读:安必平(688393)预计2025年全年归属净利润亏损4200万元至5200万元
证券之星 · 02-02
股市必读:安必平(688393)预计2025年全年归属净利润亏损4200万元至5200万元
每周股票复盘:安必平(688393)2025年净利预亏4200万至5200万元
证券之星 · 02-01
每周股票复盘:安必平(688393)2025年净利预亏4200万至5200万元
安必平:预计2025年全年扣非后净利润亏损6200万元至7200万元
证券之星 · 01-30
安必平:预计2025年全年扣非后净利润亏损6200万元至7200万元
安必平(688393.SH)发预亏,预计2025年归母净亏损4200万元到5200万元
智通财经 · 01-30
安必平(688393.SH)发预亏,预计2025年归母净亏损4200万元到5200万元
每周股票复盘:南京干靖拟减持安必平(688393)不超1.61%股份
证券之星 · 01-25
每周股票复盘:南京干靖拟减持安必平(688393)不超1.61%股份
安必平(688393.SH)股东南京干靖拟减持不超1.61%股份
智通财经 · 01-18
安必平(688393.SH)股东南京干靖拟减持不超1.61%股份
每周股票复盘:安必平(688393)补选非独立董事获股东会通过
证券之星 · 01-18
每周股票复盘:安必平(688393)补选非独立董事获股东会通过
安必平(688393)披露补选非独立董事议案获股东会通过,1月14日股价上涨2.11%
证券之星 · 01-14
安必平(688393)披露补选非独立董事议案获股东会通过,1月14日股价上涨2.11%
每周股票复盘:安必平(688393)股东减持1%股份完成
证券之星 · 01-11
每周股票复盘:安必平(688393)股东减持1%股份完成
1月9日安必平(688393)龙虎榜数据:游资章盟主上榜
证券之星 · 01-09
1月9日安必平(688393)龙虎榜数据:游资章盟主上榜
安必平(688393)披露2025年10-12月获得多项医疗器械及知识产权资质,1月8日股价上涨6.73%
证券之星 · 01-08
安必平(688393)披露2025年10-12月获得多项医疗器械及知识产权资质,1月8日股价上涨6.73%
安必平(688393)披露非独立董事候选人提名,1月7日股价上涨0.78%
证券之星 · 01-07
安必平(688393)披露非独立董事候选人提名,1月7日股价上涨0.78%
每周股票复盘:安必平(688393)股东减持68.58万股,AI辅助诊断迎政策机遇
证券之星 · 01-02
每周股票复盘:安必平(688393)股东减持68.58万股,AI辅助诊断迎政策机遇
加载更多
公司概况
公司名称:
广州安必平医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-20
主营业务:
广州安必平医药科技股份有限公司的主营业务是肿瘤筛查及诊断试剂、自动化设备及辅助诊断人工智能软件等。公司的主要产品是肿瘤筛查及诊断试剂、自动化设备、辅助诊断人工智能软件。公司共拥有三类医疗器械注册证16项,二类医疗器械注册证9项,一类医疗器械备案证579项;共拥有发明专利35项,实用新型专利87项,外观设计专利38项,软件著作权85项。
发行价格:
30.56
{"stockData":{"symbol":"688393","market":"SH","secType":"STK","nameCN":"安必平","latestPrice":22.75,"timestamp":1775199601000,"preClose":23.89,"halted":0,"volume":1691804,"delay":0,"changeRate":-0.0477,"floatShares":93567700,"shares":93567700,"eps":-0.2043,"marketStatus":"已收盘","change":-1.14,"latestTime":"04-03 15:00:01","open":23.66,"high":24.03,"low":22.71,"amount":38916000,"amplitude":0.0553,"askPrice":22.75,"askSize":35,"bidPrice":22.74,"bidSize":30,"shortable":0,"etf":0,"ttmEps":-0.2043,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775525400000},"marketStatusCode":5,"adr":0,"adjPreClose":23.89,"symbolType":"stock_kcb","openAndCloseTimeList":[[1775179800000,1775187000000],[1775192400000,1775199600000]],"highLimit":26.28,"lowLimit":21.5,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":93567699,"isCdr":false,"pbRate":1.74,"roa":"--","roe":"--","epsLYR":0.23,"committee":0.101124,"marketValue":2129000000,"turnoverRate":0.0181,"status":1,"afterMarket":{"amount":0,"volume":0,"close":22.75,"buyVolume":200,"sellVolume":0,"time":1775201637560,"indexStatus":"已收盘 04-03 15:30:00","preClose":23.89},"floatMarketCap":2129000000},"requestUrl":"/m/hq/s/688393","defaultTab":"news","newsList":[{"id":"2624740500","title":"安必平(688393)发布关于变更项目合伙人及签字会计师的公告,4月2日股价下跌3.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624740500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624740500?lang=zh_cn&edition=full","pubTime":"2026-04-02 23:08","pubTimestamp":1775142495,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘,安必平报收于23.89元,较前一交易日下跌3.28%,最新总市值为22.35亿元。近日,广州安必平医药科技股份有限公司发布公告称,因原项目合伙人、签字注册会计师熊树蓉离职,中汇会计师事务所指派肖强光接替其担任公司2025年度财务报表及内部控制审计的项目合伙人及签字注册会计师。肖强光具备专业胜任能力,符合独立性要求,近三年签署及复核4家上市公司审计报告,曾于2025年10月24日因执业问题被深交所采取书面警示措施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200043234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623631586","title":"安必平最新公告:宫颈细胞数字病理图像辅助诊断软件获三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2623631586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623631586?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:40","pubTimestamp":1774863647,"startTime":"0","endTime":"0","summary":"安必平公告称,公司近日收到国家药监局颁发的《医疗器械注册证》,产品为宫颈细胞数字病理图像辅助诊断软件,属于Ⅲ类医疗器械,有效期至2031年3月。该软件作为辅助诊断工具,可对宫颈细胞数字病理图像进行全片分析、自动识别并标记疑似病变细胞,供执业病理医师参考,但不能作为临床诊断决策的唯一依据,不适用于宫颈癌筛查。产品未来实际销售情况取决于市场推广效果及市场需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000024445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK1574","BK1100","BK0239","159883","09997","BK1222","09996","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623330703","title":"每周股票复盘:安必平(688393)预计2026年日常关联交易额1996.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623330703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623330703?lang=zh_cn&edition=full","pubTime":"2026-03-29 05:05","pubTimestamp":1774731918,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总:安必平预计2026年度日常关联交易额度为1,996.65万元。关于预计2026年度日常关联交易额度的公告广州安必平医药科技股份有限公司预计2026年度日常关联交易额度合计为1,996.65万元,涉及向关联方购买原材料、销售产品、提供劳务及租赁资产等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622869401","title":"安必平(688393)披露预计2026年度日常关联交易额度公告,3月26日股价下跌3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622869401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622869401?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:39","pubTimestamp":1774535955,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘,安必平报收于22.69元,较前一交易日下跌3.41%,最新总市值为21.23亿元。该股当日开盘23.48元,最高23.59元,最低22.54元,成交额达2811.77万元,换手率为1.31%。公告显示,公司预计2026年度日常关联交易额度合计为1,996.65万元,涉及向关联方购买原材料、销售产品、提供劳务及租赁资产等。关联交易遵循公允、合理原则,定价参考市场价格协商确定,不存在损害公司及股东利益的情形。公司与各关联方保持独立性,不会对关联方形成较大依赖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600044767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173700785","title":"方舟健客任命医疗行业资深人士王海蛟为首席执行官,此前公司创下年度增长与盈利纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=1173700785","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173700785?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:45","pubTimestamp":1774529113,"startTime":"0","endTime":"0","summary":"在实现创纪录的年度增长和盈利能力后,方舟健客宣布任命医疗行业资深人士王海蛟为公司首席执行官。此项人事任命标志着公司在强劲业绩基础上,进一步强化核心管理团队的战略举措。\n王海蛟在医疗健康领域拥有深厚的行业经验和卓越的领导履历,他的加入有望为方舟健客下一阶段的业务拓展和战略深化注入新的动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06086","688393","BK1247","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616647845","title":"每周股票复盘:安必平(688393)2025年净亏4497万","url":"https://stock-news.laohu8.com/highlight/detail?id=2616647845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616647845?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:48","pubTimestamp":1772304491,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,安必平报收于27.58元,较上周的27.67元下跌0.33%。本周,安必平2月24日盘中最高价报28.01元。本周关注点业绩披露要点:安必平2025年归属净利润亏损4,497.17万元,同比减少311.22%。公司公告汇总广州安必平医药科技股份有限公司发布2025年度业绩快报,营业总收入34,726.91万元,同比下降26.24%;营业利润-5,191.28万元,同比下降571.86%;归属于母公司所有者的净利润-4,497.17万元,同比下降311.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614880207","title":"安必平发布2025年度业绩快报,亏损0.45亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614880207","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614880207?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181057,"startTime":"0","endTime":"0","summary":"证券之星消息,安必平近日即将发布2025年年报,根据2月27日发布的业绩快报,归属净利润亏损0.45亿元,同比减少311.22%。报告期末,公司总资产 129,086.81 万元,较报告期初减少 5.27%;归属于母公司的所有者权益 119,003.73 万元,较报告期初减少 5.23%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700026508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608889572","title":"股市必读:安必平(688393)预计2025年全年归属净利润亏损4200万元至5200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608889572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608889572?lang=zh_cn&edition=full","pubTime":"2026-02-02 03:21","pubTimestamp":1769973670,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,安必平报收于27.84元,下跌0.82%,换手率3.19%,成交量2.98万手,成交额8267.45万元。来自:安必平2025年业绩预亏主因HPV产品线售价下降导致收入减少约4,650万元,毛利减少约4,600万元,并叠加研发投入增加及资产减值影响。安必平发布业绩预告,预计2025年全年扣非后净利润亏损6200万元至7200万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608431077","title":"每周股票复盘:安必平(688393)2025年净利预亏4200万至5200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608431077","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608431077?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:04","pubTimestamp":1769886253,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,安必平报收于27.84元,较上周的30.17元下跌7.72%。本周,安必平1月26日盘中最高价报30.65元。安必平当前最新总市值26.05亿元,在医疗器械板块市值排名120/127,在两市A股市值排名4892/5184。安必平发布业绩预告,预计2025年全年归属净利润亏损4200万元至5200万元。业绩下滑主要因HPV产品线售价下降导致收入减少约4,650万元,毛利减少约4,600万元,以及研发投入增加和资产减值计提所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607738090","title":"安必平:预计2025年全年扣非后净利润亏损6200万元至7200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607738090","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607738090?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:44","pubTimestamp":1769762674,"startTime":"0","endTime":"0","summary":"证券之星消息,安必平发布业绩预告,预计2025年全年扣非后净利润亏损6200万元至7200万元。安必平2025年三季报显示,前三季度公司主营收入2.53亿元,同比下降28.29%;归母净利润-1076.71万元,同比下降136.34%;扣非净利润-1694.49万元,同比下降174.5%;其中2025年第三季度,公司单季度主营收入9352.3万元,同比下降24.95%;单季度归母净利润173.14万元,同比下降86.95%;单季度扣非净利润-223.26万元,同比下降118.27%;负债率8.64%,投资收益85.61万元,财务费用-361.35万元,毛利率64.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000028149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607922990","title":"安必平(688393.SH)发预亏,预计2025年归母净亏损4200万元到5200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607922990","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607922990?lang=zh_cn&edition=full","pubTime":"2026-01-30 15:59","pubTimestamp":1769759989,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安必平(688393.SH)发布公告,公司预计2025年年度实现归属于母公司所有者的净利润-5200万元到-4200万元,与上年同期(法定披露数据)相比,将出现亏损,减少7,329.13万元到6,329.13万元,同比减少344.23%到297.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"安必平(688393.SH)发预亏,预计2025年归母净亏损4200万元到5200万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606320502","title":"每周股票复盘:南京干靖拟减持安必平(688393)不超1.61%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2606320502","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606320502?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:14","pubTimestamp":1769282052,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,安必平报收于30.17元,较上周的30.49元下跌1.05%。本周关注点公司公告汇总:南京干靖拟减持安必平不超过1.61%股份,减持方式包括集中竞价和大宗交易。公司公告汇总股东减持股份计划公告截至公告披露日,南京干靖持有广州安必平医药科技股份有限公司1,502,343股,占总股本的1.61%,股份来源于IPO前取得。其中集中竞价减持不超过935,676股,大宗交易减持不超过566,667股,减持期间为2026年2月9日至2026年5月8日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604357920","title":"安必平(688393.SH)股东南京干靖拟减持不超1.61%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2604357920","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604357920?lang=zh_cn&edition=full","pubTime":"2026-01-18 16:13","pubTimestamp":1768724027,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安必平(688393.SH)公告,公司股东南京干靖拟通过集中竞价方式及大宗交易方式减持所持有的公司股份不超过150.23万股(含本数),不超过公司目前总股本的1.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604824923","title":"每周股票复盘:安必平(688393)补选非独立董事获股东会通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2604824923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604824923?lang=zh_cn&edition=full","pubTime":"2026-01-18 02:19","pubTimestamp":1768673948,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,安必平报收于30.49元,较上周的33.04元下跌7.72%。本周,安必平1月13日盘中最高价报38.96元。本周关注点公司公告汇总:安必平2026年第一次临时股东会审议通过补选非独立董事议案。会议审议通过了关于补选公司非独立董事的议案,对中小投资者进行了单独计票。本次股东会审议通过了补选公司非独立董事的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603614343","title":"安必平(688393)披露补选非独立董事议案获股东会通过,1月14日股价上涨2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603614343","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603614343?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:12","pubTimestamp":1768399938,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘,安必平报收于34.8元,较前一交易日上涨2.11%,最新总市值为32.56亿元。该股当日开盘35.03元,最高38.27元,最低33.83元,成交额达5.39亿元,换手率为15.98%。公司近日发布公告称,广州安必平医药科技股份有限公司于2026年1月14日召开2026年第一次临时股东会,会议审议通过了关于补选公司非独立董事的议案。出席会议的股东及代理人共42人,代表有表决权股份32,922,336股,占公司总股本的35.1856%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400041148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602331785","title":"每周股票复盘:安必平(688393)股东减持1%股份完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2602331785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602331785?lang=zh_cn&edition=full","pubTime":"2026-01-11 01:56","pubTimestamp":1768067769,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,安必平报收于33.04元,较上周的23.69元上涨39.47%。本周,安必平1月9日盘中最高价报33.12元。本周关注点来自交易信息汇总:安必平因日收盘价涨幅达15%登上龙虎榜。本次减持计划实施前,诸暨高特佳及其一致行动人合计持有安必平6,292,662股,占总股本6.7253%。2025年11月6日,相关股东披露减持计划,拟通过集中竞价方式减持不超过935,676股,不超过公司总股本的1.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602218263","title":"1月9日安必平(688393)龙虎榜数据:游资章盟主上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2602218263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602218263?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:36","pubTimestamp":1767951364,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年1月9日公布的交易公开信息显示,安必平因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年1月9日收盘,安必平报收于33.04元,上涨19.71%,换手率16.78%,成交量15.7万手,成交额4.91亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出901.82万元。章盟主等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900028750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601398746","title":"安必平(688393)披露2025年10-12月获得多项医疗器械及知识产权资质,1月8日股价上涨6.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601398746","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601398746?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:39","pubTimestamp":1767883153,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘,安必平报收于27.6元,较前一交易日上涨6.73%,最新总市值为25.82亿元。该股当日开盘25.86元,最高28.2元,最低25.75元,成交额达1.89亿元,换手率为7.43%。公司近日发布公告称,广州安必平医药科技股份有限公司及子公司在2025年10-12月期间获得国内医疗器械备案证9项、知识产权类资质3项,其中包括发明专利2项、实用新型专利1项、计算机软件著作权1项,以及日本发明专利1项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800039318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","09996","688393","BK0239","BK1222","BK1574","09997","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601801352","title":"安必平(688393)披露非独立董事候选人提名,1月7日股价上涨0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801352","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801352?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:27","pubTimestamp":1767796037,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘,安必平报收于25.86元,较前一交易日上涨0.78%,最新总市值为24.2亿元。该股当日开盘25.51元,最高26.18元,最低25.2元,成交额达7591.21万元,换手率为3.15%。该议案已于2025年12月29日经第四届董事会第十一次会议审议通过,并提请股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700039004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600036257","title":"每周股票复盘:安必平(688393)股东减持68.58万股,AI辅助诊断迎政策机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036257","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036257?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:15","pubTimestamp":1767294911,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,安必平报收于23.99元,较上周的24.95元下跌3.85%。变动期间该股股价下跌3.84%,截止12月30日收盘报23.8元。关于合计持股5%以上股东权益变动触及1%刻度的提示性公告广州安必平医药科技股份有限公司公告,诸暨高特佳睿安投资合伙企业及其一致行动人于2025年12月1日至12月30日通过集中竞价交易方式合计减持公司股份685,772股,占公司总股本的0.73%。本次权益变动后,合计持股比例由6.73%减少至5.99%,触及1%刻度变动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775280937356,"stockEarnings":[{"period":"1week","weight":-0.0348},{"period":"1month","weight":-0.0907},{"period":"3month","weight":-0.0397},{"period":"6month","weight":-0.1473},{"period":"1year","weight":-0.3457},{"period":"ytd","weight":-0.0397}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.0224},{"period":"6month","weight":-0.0007},{"period":"1year","weight":0.161},{"period":"ytd","weight":-0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州安必平医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7567人(较上一季度减少17.94%)","perCapita":"12365股","listingDate":"2020-08-20","address":"广东省广州市黄埔区科学城风信路科信街2号","registeredCapital":"9356万元","survey":" 广州安必平医药科技股份有限公司的主营业务是肿瘤筛查及诊断试剂、自动化设备及辅助诊断人工智能软件等。公司的主要产品是肿瘤筛查及诊断试剂、自动化设备、辅助诊断人工智能软件。公司共拥有三类医疗器械注册证16项,二类医疗器械注册证9项,一类医疗器械备案证579项;共拥有发明专利35项,实用新型专利87项,外观设计专利38项,软件著作权85项。","listedPrice":30.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安必平(688393)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安必平(688393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安必平,688393,安必平股票,安必平股票老虎,安必平股票老虎国际,安必平行情,安必平股票行情,安必平股价,安必平股市,安必平股票价格,安必平股票交易,安必平股票购买,安必平股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安必平(688393)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安必平(688393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}